Malignant hyperthermia is a rare diagnosis, but nonetheless one worth being aware of. Very rarely, malignant hyperthermia may be triggered by succinylcholine, causing it to present initially in the emergency department or ICU. Far more often, malignant hyperthermia will be diagnosed in the operating room – with intensivists involved in providing follow-up care.
-
The IBCC chapter is located 👉 here.
- The podcast & comments are below.
Follow us on iTunes
Josh is the creator of PulmCrit.org. He is an associate professor of Pulmonary and Critical Care Medicine at the University of Vermont.
Latest posts by Josh Farkas (see all)
- IBNCC – Neurological complications of COVID - June 25, 2022
- IBNCC – Acute Demyelinating Disorders - June 23, 2022
- IBNCC – EEG interpretation and ictal-interictal continuum - June 13, 2022
Hi Josh, a few points to add for MH in the operating theatre:
– while implied by your point about hyperventilation, it is probably worth saying explicitly to turn off the volatile anaesthetic and remove the vaporisers
– as a corollary to this, you will often need to give a TIVA anaesthetic if surgery can’t be ceased urgently
– mixing dantrolene is hard work and will require multiple people assigned to this
– in Australia and NZ, a task card system (http://malignanthyperthermia.org.au/mh-task-cards/) is commonly included in the MH box/cart. This is an invaluable resource for team management in these crises